Viking Therapeutics (VKTX.US) weight loss drug emerges as a dark horse, challenging the dominance of the 'Norlevo Brothers'.
Data released earlier on Monday by viking therapeutics shows that novo-nordisk a/s and eli lilly and co, currently dominating the obesity drug field, may face fierce competition in the future.
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
Big Pharma's Obesity Bonanza Faces New Tests -- Heard on the Street -- WSJ
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
Viking Stock Drops 13% After Jumping 9% on Obesity Drug Data
Eli Lilly (NYSE:LLY) Stock Falls as Competitors Report Progress
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}